These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38828787)

  • 1. Site-specific regulation of RNA editing with ribose-modified nucleoside analogs in ADAR guide strands.
    Jauregui-Matos V; Jacobs O; Ouye R; Mozumder S; Salvador PJ; Fink KD; Beal PA
    Nucleic Acids Res; 2024 Jul; 52(12):6733-6747. PubMed ID: 38828787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside analogs in ADAR guide strands targeting 5'-UA̲ sites.
    Brinkman HF; Jauregui Matos V; Mendoza HG; Doherty EE; Beal PA
    RSC Chem Biol; 2023 Jan; 4(1):74-83. PubMed ID: 36685257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current strategies for Site-Directed RNA Editing using ADARs.
    Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
    Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing.
    Vesely C; Jantsch MF
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
    Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
    Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2.
    Yi-Brunozzi HY; Easterwood LM; Kamilar GM; Beal PA
    Nucleic Acids Res; 1999 Jul; 27(14):2912-7. PubMed ID: 10390533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Fluorescent Adenosine Analogue as a Substrate for an A-to-I RNA Editing Enzyme.
    Mizrahi RA; Shin D; Sinkeldam RW; Phelps KJ; Fin A; Tantillo DJ; Tor Y; Beal PA
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8713-6. PubMed ID: 26095193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. irCLASH reveals RNA substrates recognized by human ADARs.
    Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
    Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing adenosine-to-inosine editing reactions using RNA-containing nucleoside analogs.
    Maydanovych O; Easterwood LM; Cui T; Véliz EA; Pokharel S; Beal PA
    Methods Enzymol; 2007; 424():369-86. PubMed ID: 17662850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revealing Differential RNA Editing Specificity of Human ADAR1 and ADAR2 in
    Zhang N; Chen P; Cui Z; Zhou X; Hao C; Xie B; Hao P; Ye BC; Li X; Jing X
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA.
    Zheng Y; Lorenzo C; Beal PA
    Nucleic Acids Res; 2017 Apr; 45(6):3369-3377. PubMed ID: 28132026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICLAMP: a novel technique to explore adenosine deamination via inosine chemical labeling and affinity molecular purification.
    Yang Y; Nakayama K; Okada S; Sato K; Wada T; Sakaguchi Y; Murayama A; Suzuki T; Sakurai M
    FEBS Lett; 2024 May; 598(9):1080-1093. PubMed ID: 38523059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing.
    Xiang Y; Katrekar D; Mali P
    Methods; 2022 Sep; 205():158-166. PubMed ID: 35779766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.
    Walkley CR; Li JB
    Genome Biol; 2017 Oct; 18(1):205. PubMed ID: 29084589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside analogs in the study of the epitranscriptome.
    Palumbo CM; Beal PA
    Methods; 2019 Mar; 156():46-52. PubMed ID: 30827466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR activation by inducing a syn conformation at guanosine adjacent to an editing site.
    Doherty EE; Karki A; Wilcox XE; Mendoza HG; Manjunath A; Matos VJ; Fisher AJ; Beal PA
    Nucleic Acids Res; 2022 Oct; 50(19):10857-10868. PubMed ID: 36243986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.